Wednesday 17 February | |
British American Tobacco PLC | Full Year Results |
Burford Capital Ltd | Trading Statement |
Gattaca PLC | Trading Statement |
Hochschild Mining PLC | Full Year Results |
Plus500 Ltd | Full Year Results |
Rio Tinto PLC | Full Year Results |
Transense Technologies PLC | Half Year Results |
Thursday 18 February | |
Arbuthnot Banking Group PLC | Trading Statement |
Barclays PLC | Full Year Results |
Hays PLC | Half Year Results |
Hochschild Mining PLC | Full Year Results |
Indivior PLC | Full Year Results |
Moneysupermarket.com Group PLC | Full Year Results |
Primary Health Properties PLC | Full Year Results |
Smith & Nephew PLC | Full Year Results |
South32 Ltd | Half Year Results |
Trifast PLC | Trading Statement |
Wilmington PLC | Half Year Results |
Friday 19 February | |
Kingspan Group PLC | Full Year Results |
NatWest Group PLC | Full Year Results |
SEGRO PLC | Full Year Results |
TBC Bank Group PLC | Full Year Results |
Monday 22 February | |
Associated British Foods PLC | Trading Statement |
Benchmark Holdings PLC | Q1 Results |
Dechra Pharmaceuticals PLC | Half Year Results |
Finsbury Food Group PLC | Half Year Results |
Fonix Mobile PLC | Half Year Results |
Kosmos Energy Ltd | Q4 Results |
President Energy PLC | Trading Statement |
Sylvania Platinum Ltd | Half Year Results |
Tristel PLC | Half Year Results |
Tuesday 23 February | |
Diurnal Group PLC | Half Year Results |
McBride PLC | Half Year Results |
Clinigen Group PLC | Half Year Results |
Springfield Properties PLC | Half Year Results |
HSBC Holdings PLC | Full Year Results |
InterContinental Hotels Group PLC | Full Year Results |
Conduit Holdings Ltd | Full Year Results |
Copyright 2021 Alliance News Limited. All Rights Reserved. |
Diurnal submits application for 'Alkindi Sprinkle' to US FDA
(Sharecast News) - Specialty pharmaceutical company Diurnal Group has submitted a 'New Drug Application' (NDA) to the US Food and Drug Administration (FDA), for the regulatory approval of 'Alkindi Sprinkle', or hydrocortisone granules in capsules for opening, as a replacement therapy of adrenal insufficiency in infants, children and adolescents in the US, it announced on Monday.
Read more